Important note

This AI stock analysis for Intuitive Surgical is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!


Intuitive Surgical - AI Stock Analysis

Analysis generated February 23, 2025

Intuitive Surgical, Inc. (NASDAQ: ISRG) is at the forefront of minimally invasive robotic-assisted surgical technologies. The company's flagship product, the da Vinci Surgical System, has revolutionized the field of surgery by enhancing surgical precision, reducing recovery times, and improving patient outcomes. Established in 1995 and headquartered in Sunnyvale, California, Intuitive Surgical continues to innovate, releasing enhancements and new instruments for the da Vinci System, alongside a suite of innovative digital tools that empower surgeons around the world.

Fundamental Analysis

Intuitive Surgical has exhibited strong financial performance recently. Revenue for the last quarter stood at $2.55 billion, reflecting a substantial 14.03% growth from the previous quarter and a 22.51% increase year over year. This performance indicates robust demand for Intuitive Surgical’s offerings and a continuous upward trajectory in sales. Effective cost control and increased sales volume have also bolstered profitability.

The net income for the previous quarter was $686 million, showcasing a solid 21.34% growth compared to the quarter before it and a 13.11% rise year over year. Furthermore, the company's EBITDA was $738 million, marking a significant 27.07% increase compared to the preceding quarter and an impressive 62.09% year-over-year growth. These numbers highlight strong operational efficiency and profitability.

However, the current price-to-earnings (P/E) ratio stands at 92.61, which may be interpreted as high and could indicate potential overvaluation. This high valuation may potentially reflect investor optimism about future growth but also suggests caution.

Additionally, recent insider selling can sometimes be considered a bearish indicator, potentially signaling insider confidence in the stock's short-term upside is waning.

Technical Analysis

Intuitive Surgical's stock price is currently at $591.79. This represents a decline of 2.77% over the past month, which may raise short-term concerns. However, the stock has appreciated 51.83% over the past year, indicating a strong long-term uptrend.

Technical indicators present a mixed outlook. The current SMA10 is 597.35, which is slightly higher than the previous SMA10 of 597.31, suggesting a potential upward price movement. The Relative Strength Index (RSI) is at 52.7, indicating a neutral condition and no immediate signs of overbought or oversold conditions.

Alternative Data Analysis

Alternative data integrates additional insights into Intuitive Surgical's potential for growth. There has been a noticeable 15% increase in job postings over the past few months, now totalizing 362 open positions. This indicates company expansion efforts and a generally healthy growth trajectory.

Employee sentiment is highly favorable, with 93% of employees expressing a positive outlook regarding the company's future. This can positively impact productivity and innovation within the company.

Customer acquisition metrics also look promising. The company's website has seen a 300% increase in visitors, indicating an upward trend in customer interest and potential acquisition. The company maintains strong customer engagement on social media, evidenced by 16,000 followers on its Twitter page, although this metric has remained stable in recent months.

The AltIndex AI score for Intuitive Surgical is 75, suggesting a buy signal based on a comprehensive evaluation of fundamental, technical, and alternative data.

Conclusion and Recommendation

Intuitive Surgical displays robust financial health with significant growth in revenue, net income, and EBITDA. Despite the high P/E ratio suggesting potential overvaluation, strong operational performance and positive alternative data signals—like increased job openings and positive employee sentiment—highlight the company's growth capacity.

The technical analysis paints a nuanced picture, with recent short-term price declines but a solid long-term bullish trend. Neutral RSI and marginally increasing SMA10 signal no immediate trading risks but call for cautious optimism.

Given the comprehensive analysis, it is recommended to consider Intuitive Surgical as a potential addition to a diversified portfolio while keeping an eye on market developments and insider activity for any potential changes in outlook.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.